US Stock MarketDetailed Quotes

TYRA TYRA BIOSCIENCES, INC.

Watchlist
  • 16.420
  • +0.030+0.18%
Close Nov 4 16:00 ET
  • 16.950
  • +0.530+3.23%
Post 17:12 ET
867.08MMarket Cap-9658P/E (TTM)

About TYRA BIOSCIENCES, INC. Company

Tyra Biosciences, Inc. is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Its proprietary in-house discovery platform, SN?P, enables the rapid and precise refinement of structural design through iterative molecular SN?Pshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA is developing a pipeline of selective inhibitors of the Fibroblast Growth Factor Receptor (FGFR) family members, which are altered in approximately 7% of all cancers. The company was founded by Daniel Bensen and Todd Harris on August 2, 2018 and is headquartered in Carlsbad, CA.

Company Profile

SymbolTYRA
Company NameTYRA BIOSCIENCES, INC.
Listing DateSep 15, 2021
Issue Price16.00
Founded2018
CEODr. Todd Harris, PhD
MarketNASDAQ
Employees49
Fiscal Year Ends12-31
Address2656 State Street
CityCarlsbad
ProvinceCalifornia
CountryUnited States of America
Zip Code92008
Phone1-619-728-4760

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Todd Harris, PhD
  • President, Chief Executive Officer and Director
  • 4.63M
  • Dr. Hiroomi Tada, M.D.,PhD
  • Chief Medical Officer
  • 2.41M
  • Daniel Bensen
  • Chief Operating Officer
  • --
  • Alan Fuhrman
  • Chief Financial Officer and Principal Accounting Officer
  • 3.53M
  • Robert J. More
  • Chairman of the Board
  • 231.55K
  • Dr. S. Michael Rothenberg, M.D.
  • Independent Director
  • --
  • Nina Kjellson
  • Independent Director
  • 196.05K
  • Dr. Jake Sin, PhD
  • Independent Director
  • 200.05K
  • Rehan Verjee
  • Independent Director
  • 201.05K
  • Dr. Susan Moran, M.D.
  • Independent Director
  • --
  • Dr. Melissa McCracken, PhD
  • Independent Director
  • --
  • Dr. Gilla Kaplan,PhD
  • Independent Director
  • 195.05K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data